Compugen Ltd (Israel) Profile

Performance

   

 Odds of Distress 

Check how we calculate scores
Equity ratings for Compugen Ltd are calculated based on Macroaxis scoring framework. The performance scores are derived for the period starting March 27, 2019 and ending today May 26, 2019. Click here to learn more.
1,227
ILS 7  0.57%

Compugen Ltd Summary

Compugen Ltd (CGEN) is traded on Tel Aviv Stock Exchange in Israel and employs 89 people. The company currently falls under 'Small-Cap' category with current market capitalization of 772.79M. Compugen Ltd operates under Healthcare sector and is part of Biotechnology industry. The entity has 57.21M outstanding shares. COMPUGEN has accumulated about 45.07M in cash with (13.29M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.75.
Check Compugen Ltd Probability Of Bankruptcy

Compugen Ltd Target Price Odds Analysis

Odds Below 1227.0HorizonTargetOdds Above 1227.0
20.19%30 days 1,227 79.68%
Based on normal probability distribution, the odds of Compugen Ltd to move above current price in 30 days from now is about 79.68% (This Compugen Ltd probability density function shows the probability of Compugen Ltd Stock to fall within a particular range of prices over 30 days) .

Compugen Ltd Top Holders

Compugen Ltd Income Statement Over Time

Net Income    Revenues    

Compugen Ltd Key Fundamentals

Compugen Ltd Vital Trading Data

Compugen Ltd., a therapeutic discovery company, engages in the research, development, and commercialization of therapeutic and product candidates in Israel, the United States, and Europe. The company was incorporated in 1993 and is headquartered in Holon, Israel. Compugen Ltd operates under Biotechnology classification in Israel and is traded on Tel Aviv Stock Exchange. It employs 89 people. more
NameCompugen Ltd
President CEO, DirectorAnat CohenDayagView All
Macroaxis Advice
InstrumentIsrael Stock View All
RegionMiddle East
Business AddressBuilding D
Foreign Associate  USA
ExchangeTel Aviv Stock Exchange
CIK Number0001119774
SectorHealthcare
IndustryBiotechnology
BenchmarkDOW
Websitewww.cgen.com
Phone972 3 765 8585
CurrencyILS - Israeli Shekel
Next Fiscal Year EndDecember 31, 2020
Most Recent QuarterDecember 31, 2018
Last Fiscal Year EndDecember 31, 2018

Compugen Ltd Corporate Directors

Joshua Shemer Independent External Director
Michal Preminger Director
Dov Hershberg Director
Check also Trending Equities. Please also try Alpha Finder module to use alpha and beta coefficients to find investment opportunities after accounting for the risk.
Search macroaxis.com